Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
0.7%
1w
3.2%
1m
13.7%
3m
20.0%
6m
12.5%
all
7.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 784 0.7%
608
805
Company Overview

Sales
2,011 Cr
Growth: 47.6%
Profit after Tax
526 Cr
Growth: -11.6%
Large Cap
44,041 Cr
P/E: 84.0x
Industry P/E: 30.6x
Fundamentals

Sales (Cr) ₹ 2,011
Growth 47.6%
EBITDA 36.1%
P/S 21.9x
Dividend 0.0%
P/E 84.0x
Book Value ₹ 2
PEG Ratio 1.8x
ROE 469.2%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)